Pfizer, union launch anti-smoking campaign for firefighters

Share this article:
Pfizer is teaming up with a firefighters' union for a smoking cessation campaign aimed at making the International Association of Fire Fighters (IAFF) "the first smoke-free union."

The campaign features a website advising firefighters on the risks of smoking and how to quit and featuring video messages from Pfizer CEO Jeff Kindler and IAFF general president Harold Schaitberger. Additional resources are coming soon, including a DVD with stories from firefighters about quitting.

Firefighters, the company and the union noted, already face elevated risk for smoking-related illnesses including heart disease, respiratory disease and certain cancers. Smoking is also the leading cause of fires.

“We congratulate the IAFF for its commitment to this campaign and look forward to working together toward the goal of a smoke-free union,” said Kindler in a statement. “Firefighters are respected leaders in their communities, and this program on smoking cessation reaffirms that leadership.”

Pfizer makes smoking cessation treatment Chantix. The Pfizer-IAFF campaign is unbranded, though clicking a link on the main page of the website takes you to a run-down of treatment options, including Chantix, produced by the Smoking Cessation Leadership Center, a program of the Robert Wood Johnson Foundation whose partners include Pfizer.
Share this article:
You must be a registered member of MMM to post a comment.


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...